Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non-Current Debt (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Non-Current Debt readings, the most recent being $249500.0 for Q1 2026.

  • On a quarterly basis, Non-Current Debt changed 0.0% to $249500.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $249500.0, a 0.0% change, with the full-year FY2025 number at $249500.0, changed 0.06% from a year prior.
  • Non-Current Debt reached $249500.0 in Q1 2026 per CBIH's latest filing, roughly flat from $249500.0 in the prior quarter.
  • The five-year high for Non-Current Debt was $249501.0 in Q1 2025, with the low at $249361.0 in Q2 2024.
  • A 4-year average of $249487.5 and a median of $249500.0 in 2023 define the central range for Non-Current Debt.
  • Year-over-year, Non-Current Debt decreased 0.06% in 2024 and then rose 0.06% in 2025.
  • Year by year, Non-Current Debt stood at $249500.0 in 2023, then changed by 0.0% to $249500.0 in 2024, then changed by 0.0% to $249500.0 in 2025, then changed by 0.0% to $249500.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Non-Current Debt are $249500.0 (Q1 2026), $249500.0 (Q4 2025), and $249500.0 (Q3 2025).